| 1 |
Hillis S, N′Konzi JN, Msemburi W, et al. Orphanhood and caregiver loss among children based on new global excess COVID-19 death estimates[J]. JAMA Pediatr, 2022，176(11)：1145-1148.
|
| 2 |
Danziger-Isakov L, Blumberg EA, Manuel O, et al. Impact of COVID-19 in solid organ transplant recipients[J]. Am J Transplant, 2021，21(3)：925-937.
|
| 3 |
Heldman MR, Kates OS, Safa K, et al. Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic[J]. Am J Transplant, 2022，22(1)：279-288.
|
| 4 |
Radcliffe C, Palacios CF, Azar MM, et al. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge[J]. Am J Transplant, 2022，22(10)：2458-2463.
|
| 5 |
王欢，张铖. 口服新型冠状病毒肺炎治疗新药——Paxlovid[J]. 临床药物治疗杂志，2022，20(2)：13-17.
|
| 6 |
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中华临床感染病杂志，2023，16(1)：1-9.
|
| 7 |
Reis S, Metzendorf MI, Kuehn R, et al. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19[J]. Cochrane Database Syst Rev, 2022，9(9): CD015395.
|
| 8 |
全国移植药师联盟，浙江省医院药事管理质控中心. 器官移植受者新型冠状病毒感染入院治疗药物使用建议(2023版)[J/CD]. 中华移植杂志：电子版，2023，17(1)：17-31.
|
| 9 |
Devresse A, Sébastien B, De Greef J, et al. Safety, efficacy, and relapse of nirmatrelvir-ritonavir in kidney transplant recipients infected with SARS-CoV-2[J]. Kidney Int Rep, 2022，7(11)：2356-2363.
|
| 10 |
王钊，刘鹤松，王秀云. 奈玛特韦片/利托那韦片药物相互作用与用药指导[J]. 临床药物治疗杂志，2023，21(1)：21-26.
|
| 11 |
尚庆香，许可，戴启刚，等. 新型冠状病毒Omicron变异株引起的续发率及影响因素研究[J]. 中华预防医学杂志，2023，57(10)：1550-1557.
|
| 12 |
Ng TI, Correia I, Seagal J, et al. Antiviral drug discovery for the treatment of COVID-19 infections[J]. Viruses, 2022，14(5)：961.
|
| 13 |
Mazzitelli M, Mengato D, Sasset L, et al. Molnupiravir and nirmatrelvir/ritonavir: tolerability, safety, and adherence in a retrospective cohort study[J]. Viruses, 2023，15(2)：384.
|
| 14 |
Hedvat J, Lange NW, Salerno DM, et al. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era[J]. Am J Transplant, 2022，22(11)：2682-2688.
|
| 15 |
地里亚尔·地里夏提，凯赛尔江·卡地尔，拜合提亚·阿扎提，等. 肾移植术后新型冠状病毒感染受者院内死亡影响因素的系统评价与Meta分析[J]. 中华器官移植杂志，2023，44(1)：31-39.
|
| 16 |
Li H, Gao M, You H, et al. Association of nirmatrelvir/ritonavir treatment on upper respiratory severe acute respiratory syndrome coronavirus 2 reverse transcription-polymerase chain reaction (SARS-Cov-2 RT-PCR) negative conversion rates among high-risk patients with coronavirus disease 2019 (COVID-19)[J]. Clin Infect Dis, 2023，76(3): e148-e154.
|
| 17 |
巨春蓉，李宁，邱涛，等. 器官移植受者新型冠状病毒肺炎的临床特点和疫情期间的管理策略(第1版)[J]. 器官移植，2020，11(2)：185-193.
|
| 18 |
黄倩，陈松，刘斌，等. 肾移植受者继发新型冠状病毒感染免疫抑制方案的调整[J]. 临床外科杂志，2021，29(4)：385-387.
|
| 19 |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020，8(4)：420-422.
|
| 20 |
Favà A, Cucchiari D, Montero N, et al. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: a multicentric cohort study[J]. Am J Transplant, 2020，20(11)：3030-3041.
|
| 21 |
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J]. Lancet, 2020，395(10223)：473-475.
|
| 22 |
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China[J]. JAMA Intern Med, 2020，180(7)：934-943.
|
| 23 |
Fadel R, Morrison AR, Vahia A, et al. Early short-course corticosteroids in hospitalized patients with COVID-19[J]. Clin Infect Dis, 2020，71(16)：2114-2120.
|
| 24 |
Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19[J]. N Engl J Med, 2021，384(8)：693-704.
|
| 25 |
Salerno DM, Jennings DL, Lange NW, et al. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients[J]. Am J Transplant, 2022，22(8)：2083-2088.
|
| 26 |
Guzmán CC, Saez-Torres DVM. Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series[J]. Eur J Hosp Pharm, 2022. [Online ahead of print]
|
| 27 |
Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections[J]. Nat Microbiol, 2022，7(8)：1127-1140.
|
| 28 |
中国器官移植发展基金会器官移植受者健康管理专家委员会. 器官移植受者新型冠状病毒感染防治策略与健康管理中国专家指导意见(第一版)[J/CD]. 中华移植杂志：电子版，2023，17(1)：1-12.
|
| 29 |
戚若晨，马帅军，韩士超，等. 肾移植术后新型冠状病毒感染单中心诊疗经验[J/CD]. 中华移植杂志：电子版，2023，17(4)：232-239.
|